Related Experiment Video

Updated: Aug 9, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Arterial counterpulsation in the management of ischaemic heart disease

M F O'Rourke

    The Australian and New Zealand Journal of Surgery
    |February 1, 1977
    PubMed

    Insights

    Arterial counterpulsation significantly limits myocardial ischaemia and necrosis following myocardial infarction when initiated within 24 hours. This treatment shows promise across a spectrum of infarction severity, including cardiogenic shock.

    Area of Science:

    • Cardiovascular Medicine
    • Interventional Cardiology

    Background:

    • Myocardial infarction (MI) remains a leading cause of mortality worldwide.
    • Myocardial ischaemia and subsequent necrosis are key determinants of infarct size and patient outcomes.
    • Effective interventions to limit infarct progression are crucial.

    Purpose of the Study:

    • To evaluate the efficacy of arterial counterpulsation in managing myocardial ischaemia.
    • To determine the optimal timing and patient population for counterpulsation therapy post-MI.

    Main Methods:

    • Review of clinical data and physiological principles of arterial counterpulsation.
    • Analysis of outcomes in patients with varying severities of myocardial infarction, including cardiogenic shock.

    Main Results:

    • Arterial counterpulsation demonstrates effectiveness in limiting ischaemia and necrosis.
    • Positive outcomes observed in both massive infarction with cardiogenic shock and threatening infarction scenarios.
    • Results suggest a broad applicability across the clinical spectrum of MI.

    Conclusions:

    • Arterial counterpulsation is a valuable therapeutic advance for myocardial infarction.
    • The technique is physiologically sound and effective when applied early (within 12-24 hours).
    • Further studies are ongoing to fully delineate its role in managing myocardial infarction.

    More Related Videos

    The Intra-Aortic Balloon Pump06:13

    The Intra-Aortic Balloon Pump

    Published on: February 5, 2021

    Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge09:32

    Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge

    Published on: January 20, 2023

    Related Concept Videos

    Pulse01:16

    Pulse

    When the heart pumps blood out, arterial elastic fibers play a crucial role in sustaining a high-pressure gradient. They expand to accommodate the received blood and then recoil - a process known as the pulse that can be either manually palpated or electronically quantified. Despite a reduction in its effect with increased distance from the heart, elements of the pulse's systolic and diastolic components persist, observable even at the arteriole level.
    The pulse serves as a clinical indicator...
    Aortic Regurgitation III: Medical Management01:25

    Aortic Regurgitation III: Medical Management

    Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
    Coronary Artery Disease V: Interprofessional Care01:27

    Coronary Artery Disease V: Interprofessional Care

    Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
    Angina IV: Management01:26

    Angina IV: Management

    IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
    Peripheral Artery Disease III: Interprofessional Care01:27

    Peripheral Artery Disease III: Interprofessional Care

    Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
    Peripheral Artery Disease IV: Nursing Management01:26

    Peripheral Artery Disease IV: Nursing Management

    The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...